Efficacy Study of Diacerein on Glycemic Control and Liver Fat in Type 2 Diabetes Subjects
Status:
Completed
Trial end date:
2018-01-31
Target enrollment:
Participant gender:
Summary
This study is conducted to test the hypothesis that in uncontrolled type 2 diabetic adults
treatment with diacerein will improve glycemic control and will reduce liver fat within a 24
month period.
Phase:
Phase 3
Details
Lead Sponsor:
Universidade Federal do Rio de Janeiro
Collaborator:
Rio de Janeiro State Research Supporting Foundation (FAPERJ)